- Home
- KOD vs THQ Comparison
KOD vs THQ Comparison
Compare KOD & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$22.87
Company Overview
Basic Information| Metric | KOD | THQ |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 795.5M | 753.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KOD | THQ |
|---|---|---|
| Price | $22.87 | $19.08 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $22.29 | N/A |
| AVG Volume (30 Days) | ★ 774.9K | 158.9K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $15.29 |
| 52 Week High | $23.63 | $20.38 |
Technical Indicators
Market Signals| Indicator | KOD | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 71.04 |
| Support Level | $19.25 | $17.80 |
| Resistance Level | $23.63 | $18.41 |
| Average True Range (ATR) | 1.92 | 0.32 |
| MACD | 0.24 | 0.12 |
| Stochastic Oscillator | 89.70 | 84.44 |
Price Performance
Historical Comparison KOD
THQ
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.